Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.

On August 1, 2022, HealthEquity, Inc. (the "Company") announced that Edward R. (Ted) Bloomberg, the Company's Chief Operating Officer, ceased serving as the Company's Chief Operating Officer, effective immediately. Mr. Bloomberg will serve as a Special Advisor to the Company for a limited period of time, in which role he will assist in transitioning his responsibilities as determined by Jon Kessler, the Company's President and Chief Executive Officer. The Company also announced that Mr. Kessler will assume the duties and responsibilities of the Company's principal operating officer in connection with Mr. Bloomberg's resignation.

As a Special Advisor, Mr. Bloomberg will remain entitled to the compensation and benefits provided for in his employment agreement with the Company, dated as of May 15, 2018 (the "Employment Agreement"). In consideration of Mr. Bloomberg's execution, delivery and non-revocation of the release of claims against the Company and its subsidiaries and affiliates substantially in the form attached to the Employment Agreement, and his continuing compliance with certain restrictive covenants contained therein, Mr. Bloomberg will receive the previously negotiated severance payments and benefits set forth in the Employment Agreement, as detailed in the Company's most recent proxy statement filed with the Securities and Exchange Commission on May 13, 2022.

Item 9.01 Financial Statements and Exhibits






(d) Exhibits



Exhibit No. Description

104         Cover Page Interactive Data File (formatted in Inline XBRL)




  - 2 -

© Edgar Online, source Glimpses